Ocu-Sul 15 Side Effects
Generic name: sulfacetamide sodium ophthalmic
Medically reviewed by Drugs.com. Last updated on Jul 22, 2024.
Note: This document provides detailed information about Ocu-Sul 15.
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension Side Effects associated with sulfacetamide sodium ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Ocu-Sul 15.
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution, ophthalmic suspension.
Side effects include:
Local irritation, transient stinging or burning.
For healthcare professionals
Applies to sulfacetamide sodium ophthalmic: ophthalmic ointment, ophthalmic solution.
General adverse events
The side effects reported most often were local/conjunctival irritation, stinging, and burning.[Ref]
Ocular
- Frequency not reported: Local/conjunctival irritation, stinging, burning, nonspecific conjunctivitis, conjunctival hyperemia, bacterial corneal ulcers, fungal corneal ulcers[Ref]
Hypersensitivity
- Rare (less than 0.1%): Sensitivity reactions
- Frequency not reported: Allergic reactions/hypersensitivity, local hypersensitivity progressing to fatal syndrome resembling systemic lupus erythematosus (SLE)[Ref]
At least 1 case of local hypersensitivity has been reported that progressed to a SLE-like fatal syndrome.[Ref]
Other
- Frequency not reported: Secondary infections[Ref]
Dermatologic
- Frequency not reported: Stevens-Johnson syndrome, toxic epidermal necrolysis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).
Stevens-Johnson syndrome was reported in a patient with history of blistering drug reaction to an oral sulfonamide.[Ref]
Hematologic
Sulfonamides:
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
Hepatic
Sulfonamides:
- Frequency not reported: Fulminant hepatic necrosis[Ref]
Fatalities reported rarely due to severe reactions to sulfonamides (including toxic epidermal necrolysis, Stevens-Johnson syndrome, fulminant hepatic necrosis, aplastic anemia, agranulocytosis, other blood dyscrasias).[Ref]
References
1. "Product Information. Sodium Sulamyd (sulfacetamide sodium ophthalmic)." Schering Corporation
2. Cerner Multum, Inc. "Australian Product Information."
More about Ocu-Sul 15 (sulfacetamide sodium ophthalmic)
- Check interactions
- Compare alternatives
- Dosage information
- During pregnancy
- Drug class: ophthalmic anti-infectives
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Ocu-Sul 15 side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.